Gilead Sciences Inc (GILD)

63.84
+0.57(+0.90%)
After Hours
63.99
+0.15(+0.23%)
- Real-time Data
  • Volume:
    6,727,960
  • Day's Range:
    62.72 - 63.90
  • 52 wk Range:
    57.19 - 74.12

GILD Overview

Prev. Close
63.27
Day's Range
62.72-63.9
Revenue
27.47B
Open
63.37
52 wk Range
57.19-74.12
EPS
3.58
Volume
6,727,960
Market Cap
80.08B
Dividend (Yield)
2.92
(4.57%)
Average Vol. (3m)
9,779,347
P/E Ratio
17.68
Beta
0.34
1-Year Change
-7.95%
Shares Outstanding
1,254,313,448
Next Earnings Date
Jul 27, 2022
What is your sentiment on Gilead?
or
Market is currently closed. Voting is open during market hours.

Gilead Sciences Inc News

Gilead Sciences Inc Analysis

Gilead Sciences Inc Company Profile

Gilead Sciences Inc Company Profile

Employees
14400

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
  • I’m sure we all saw the dip, i would say it’s unavoidable but Don't invest blindly in stocks or crypto when you do not have a proper guide. I lost 20k trying to trade on my own but ever since Justin Robert at daviesprofits stepped in, I have been making huge profits. I made over 650k since October. he is always available to guidance regarding crypto currency investment on face💬book Justin. Robert.45
    0
    • Who cares about dividends when this stock shows weakness year after year, is not a good deal to get 5% per year if you are constantly worried about this stock sinks under 2013 lows
      0
      • Are you a coinbase client? 😉
        0
    • it sucks...
      0
      • invest stock gild.us at basel markets to take home divedends
        0
        • Projected earnings beat but I'd bet it doesn't move the needle -
          0
          • Another 15 or so shares into this.
            1
            • I've held this since 2014 or so. COULD have picked NVDA for approx 15 - 20 😒Did I pick the winner eh?
              2
              • Amazing how GILD managed to disappoint on EVERY earnings report.
                4
                • Yes, even a beat is disapointing -
                  0
              • What's happening?!
                1
                • Everyone in market is here to make money. Gilead saved my wife's life. I will donate all my money for this one organization who is working to safe our life ...
                  1